Home » Trials » SLCTR/2025/022
Efficacy of consumption of traditional rice compared to normal rice in reducing obesity among children aged 10-14 years attending paediatric endocrine clinic at Lady Ridgeway Hospital for children, Sri Lanka: A randomized controlled trial
-
SLCTR Registration Number
SLCTR/2025/022
Date of Registration
The date of last modification
Jun 05, 2025
Scientific Title of Trial
Efficacy of consumption of traditional rice compared to normal rice in reducing obesity among children aged 10-14 years attending paediatric endocrine clinic at Lady Ridgeway Hospital for children, Sri Lanka: A randomized controlled trial
Public Title of Trial
Impact of traditional rice consumption over normal rice in reducing obesity among children aged 10-14 years attending paediatric endocrine clinic at Lady Ridgeway Hospital for children, Sri Lanka: A randomized controlled trial
Disease or Health Condition(s) Studied
Childhood obesity
Scientific Acronym
None
Public Acronym
none
Brief title
None
Universal Trial Number
U1111-1318-3673
Any other number(s) assigned to the trial and issuing authority
ERC application Number: 73/24
What is the research question being addressed?
Could consumption of Sri Lankan traditional rice compared to normal rice, reduce obesity or factors contributing to obesity in children?
Type of study
Interventional
Study design
Allocation
Randomized controlled trial
Masking
Single blinded : Data analysts, Healthcare providers, Outcome assessors
Control
Standard therapy/practice
Assignment
Parallel
Purpose
Health services research
Study Phase
Phase 3
Intervention(s) planned
Study Setting -The study will be conducted at the Department of biochemistry, Faculty of medical sciences, University of Sri Jayewardenepura and Lady Ridgeway Hospital for Children (LRH), Colombo 08, Sri Lanka.
Randomization a) Minimisation method, which is a type of covariate adaptive randomization, will be utilized to allocate the participants to intervention and control groups. Minimisation method used to minimize the imbalance across age and sex factors in intervention and control group Age and sex will be the covariates considered. The first participant will be randomly assigned to either the treatment or control group. Each subsequent participant will be assigned to study groups (intervention and control) using minimisation method to ensure balance in age and sex covariates. Minimisation will be carried out using the free software Minim. (Altman and Bland, 2005). In minim interface we will create two treatment groups as intervention and control. Sex and age will be our two covariates(factor). For sex factor two categories will be there as male and female. For age five categories as10,12,13,14,15 yrs
b) Allocation Concealment The allocation will be performed by a medical officer who is not involved with this research and Minim, a free software, will be used for minimisation. The allocation sequence will be concealed until intervention assignment, ensuring investigators and participants cannot predict or influence the allocation.
The quantity will not be restricted for the research purposes .They are advisable to consume the amount according to the guidelines given by the Pediatric consultant at the clinic visits.
The compliance of rice consumption will be assessed each week via phone call interviews. A tracking sheet will be provided to the intervention group to indicate rice consumption with the amount. Parents /guardians of the participants will be trained to fill up the sheet accurately and advised to use this rice only for the intended recipient.
The consumption pattern of other food items will be recorded via food frequency and dietary patterns questionnaire. It will be administered at the first contact point (week 0) and the mid- point (week 13) last contact point(week 26)
Both the interventional and control groups will continue with other general advice and recommendations given by the paediatric endocrine consultant on their clinic visits. Advice on portion size of carbohydrates, healthy snacks, how to avoid high calory food, importance of physical activity, limiting junk , fried, sweet food based on each child’s requirement.The ongoing normal treatment regimen designed for them by the consultant will be continuous and will not be affected by the research intervention.
Baseline (Week 0) – before intervention begins Midpoint (Week 13) – after 3 months Endpoint (Week 26) – after 6 month
Inclusion criteria
Exclusion criteria
Primary outcome(s)
1.
Absolute reduction of BMI from baseline Absolute change: BMI Week 26 – BMI Week 0 |
[ Post-Intervention (Week 26) ] |
2.
Relative change in BMI Middle of intervention: (BMI Week 13 – BMIWeek0) ÷ BMI Week0 × 100% Post-Intervention: (BMI Week 26 – BMIWeek0) ÷ BMI Week0 × 100% |
[ Middle of the intervention (Week 13) Post-Intervention (Week 26) ] |
Secondary outcome(s)
1.
Anthropometric parameters,
Measurement variable -Mid-upper arm circumference, Waist circumference, Body fat |
[ Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26) ] |
2.
Biochemical parameters Measurement variable -Fasting blood sugar (FBS), HbA1c, Insulin, Leptin levels, Lipid profile, Liver function test |
[ Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26) ] |
Target number/sample size
80 (40 in each arm)
Countries of recruitment
Sri Lanka
Anticipated start date
2025-07-01
Anticipated end date
2028-05-01
Date of first enrollment
Date of study completion
Recruitment status
Pending
Funding source
University grant-University of Sri Jayewardenepura
Regulatory approvals
N/A
Status
Approved
Date of Approval
2025-04-01
Approval number
73/24
Details of Ethics Review Committee
Name: | Research Ethics Committee ,Faculty of Medical Sciences, University of Sri Jayewardenepura |
Institutional Address: | Faculty of Medical Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri Lanka |
Telephone: | Tel.94-11-2758588 |
Email: | erc.fms@sjp.ac.lk |
Contact person for Scientific Queries/Principal Investigator
Prof. Sagarika Ekanayake
Senior Professor
Department of Biochemistry, Faculty
of Medical Sciences, University of Sri Jayewardenepura
+94 (0)716875891
sagarikae@sjp.ac.lk
Contact Person for Public Queries
Prof. Sagarika Ekanayake
Senior Professor
Department of Biochemistry, Faculty
of Medical Sciences, University of Sri Jayewardenepura
+94 (0)716875891
sagarikae@sjp.ac.lk
Primary study sponsor/organization
University of Sri Jayewardenepura
Department of Biochemistry, Faculty
of Medical Sciences, University of Sri Jayewardenepura
+94 11 2881788 Ext: 4151
fms@sjp.ac.lk
Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?
No
IPD sharing plan description
Study protocol available
No
Protocol version and date
Not Available
Protocol URL
Not Available
Results summary available
No
Date of posting results
Date of study completion
Final sample size
Date of first publication
Link to results
Brief summary of results